Carbone, D. P., Spigel, D., Ross, J. S., Murugesan, K., Li, G., Huang, R. S. P., . . . Sands, J. Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: A real-world outcomes analysis. BMJ Publishing Group.
Chicago Style (17th ed.) CitationCarbone, David P., et al. Durable Responders in Advanced NSCLC with Elevated TMB and Treated with 1L Immune Checkpoint Inhibitor: A Real-world Outcomes Analysis. BMJ Publishing Group.
MLA (9th ed.) CitationCarbone, David P., et al. Durable Responders in Advanced NSCLC with Elevated TMB and Treated with 1L Immune Checkpoint Inhibitor: A Real-world Outcomes Analysis. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.